Accessibility helpSkip to navigationSkip to contentSkip to footer
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
myFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • Americas
    • Middle East and North Africa
    Most Read
    • EU turns to US in scramble for Oxford/AstraZeneca vaccine
    • UK-EU trade falls sharply as Brexit disruption starts to bite
    • ‘After a year we’re back to square one’: Milan locked in Covid’s grasp
    • Joe Biden’s $1.9tn stimulus bill clears hurdle in Senate
    • France backs Italy’s decision to block vaccine exports to Australia
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • EU turns to US in scramble for Oxford/AstraZeneca vaccine
    • High-priced tech stocks sink further into bear market territory
    • White House warns of ‘large number’ of victims in Microsoft hack
    • Joe Biden’s $1.9tn stimulus bill clears hurdle in Senate
    • Fears rise among bond investors as Buffett warns on outlook
  • Companies
    Sections
    • Companies Home
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
    Most Read
    • Lloyds Bank plans to become private landlord
    • Pandemic fuels fast food’s appetite for UK expansion
    • FC Barcelona’s presidential hopefuls vow to restore finances — and keep Messi
    • Bank of America reaps trading windfall during Texas blackouts
    • LSE Group shares suffer biggest daily fall in more than 20 years
  • Tech
  • Markets
    Sections
    • Markets Home
    • Alphaville
    • Markets Data
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
    Most Read
    • The unravelling of Lex Greensill: a mix of bravado and financial alchemy
    • Fears rise among bond investors as Buffett warns on outlook
    • Emerging markets suffer first outflows since October on rate jump
    • US stocks climb and Treasuries gyrate after bumper jobs report
    • SEC charges AT&T and investor relations employees over calls to analysts
  • Climate
  • Opinion
    Sections
    • Opinion Home
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
    Most Read
    • Fears rise among bond investors as Buffett warns on outlook
    • This is the electric vehicle bubble. And this is the crash.
    • How gay do you feel?
    • Where regals dare: Harry and Meghan’s TV takeover
    • Ishiguro and the rise of techno-pessimism
  • Work & Careers
    Sections
    • Work & Careers Home
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    Most Read
    • Do young people really need the office?
    • FT business books: March edition
    • Should I reveal I have a difficult boss when interviewing for jobs?
    • Ideas flow as an orchestra and school team up
    • Negotiation skills prove their real-world worth
  • Life & Arts
    Sections
    • Life & Arts Home
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
    Most Read
    • Inside the ‘Covid Triangle’: a catastrophe years in the making | Free to read
    • The CEO whisperer: ‘Every leader needs a fool’
    • How gay do you feel?
    • Travels in my iPhone
    • Where regals dare: Harry and Meghan’s TV takeover
  • How to Spend It
  • Sign In
  • Subscribe
MenuSearch
  • Home
  • World
  • US
  • Companies
  • Tech
  • Markets
  • Climate
  • Opinion
  • Work & Careers
  • Life & Arts
  • How to Spend It
Financial Times
  • Sign In
  • Subscribe

$50 for your first 3 months Get the print edition and steer from crisis to recovery

Subscribe now

David Crow

US Coronavirus Correspondent
David Crow is the FT's US coronavirus correspondent in New York. His previous roles include banking editor and senior US business correspondent. He also worked on the main news desk in London. Before joining the FT in 2012, he was managing editor of City AM.
Email David Crow @bydavidcrow (link opens in a new browser window)
Email David Crow @bydavidcrow (link opens in a new browser window)

Add to myFT Digest

Add this topic to your myFT Digest for news straight to your inbox

  • Friday, 23 October, 2020
    US presidential election 2020
    Presidential debate: How our columnists rated the last Trump-Biden battle — as it happened
  • Friday, 9 October, 2020
    News in-depthRegeneron Pharmaceuticals Inc
    Regeneron: the company that Trump claims cured his Covid

    President’s championing of novel therapy thrusts biotech group into uncomfortable spotlight

  • Thursday, 8 October, 2020
    US presidential election 2020
    Vice-presidential debate: read our columnists’ analysis of Harris, Pence and the fly — as it happened
  • Wednesday, 30 September, 2020
    US presidential election 2020
    Presidential debate: our experts’ insights from the Trump-Biden duel — as it happened
  • Thursday, 27 August, 2020
    FT Magazine
    Is this the end for America’s mom-and-pop stores?

    For small family businesses already struggling against retail chains and online giants, Covid-19 threatens to be a fatal blow

  • Monday, 24 August, 2020
    Coronavirus pandemic
    Trump considers fast-tracking UK Covid-19 vaccine before US election

    Move comes as FDA gives emergency authorisation for use of plasma from recovered patients

  • Monday, 24 August, 2020
    FT News Briefing podcast10 min listen
    Trump considers vaccine fast-track, dividends fall, Marble Ridge

    Trump considers fast tracking a UK coronavirus vaccine ahead of the presidential election

  • Thursday, 20 August, 2020
    Coronavirus: free to read
    Why is the ‘anti-vaxxer’ movement growing during a pandemic?

    US concerns that Trump will rush to approve a vaccine before election is playing into wider safety fears

  • Thursday, 6 August, 2020
    Coronavirus pandemic
    The next virus pandemic is not far away

    Scientists say new diseases will jump from animals unless humans change the way they live

  • Promoted Content
  • Wednesday, 5 August, 2020
    Coronavirus treatment
    J&J strikes $1bn Covid-19 vaccine deal with US

    Moderna to sell some doses of its own coronavirus jab candidate for between $32 and $37

  • Wednesday, 22 July, 2020
    ExplainerCoronavirus pandemic
    Test, test, test — but what can America do about the delays?

    Patients in the US are waiting more than a week for results, by which time it’s probably too late

  • Tuesday, 21 July, 2020
    Coronavirus: free to read
    US lab giant warns of new Covid-19 testing crunch in autumn

    Quest Diagnostics executive says ‘no way’ capacity will expand enough to cope with flu season

  • Sunday, 19 July, 2020
    Coronavirus pandemic
    Trump under pressure on test funding as Covid-19 surges

    President says mass testing ‘skews the numbers’ as governors say more money is needed

  • Friday, 17 July, 2020
    News in-depthThe Big Read
    US coronavirus surge: ‘It’s a failure of national leadership’

    Sunbelt states suffer a big rise in cases and deaths amid the growing politicisation of issues such as wearing masks

  • Thursday, 16 July, 2020
    Coronavirus treatment
    Lie on your front: the small things in Covid-19 survival

    Doctors in sunbelt states share lessons learnt from New York in hope of limiting deaths

  • Thursday, 2 July, 2020
    Coronavirus pandemic
    Independence Day: a star-spangled superspreader event

    US public health experts warn of heightened risk of virus transmission during July 4 celebrations

  • Tuesday, 30 June, 2020
    Coronavirus pandemic
    US hospitals buckle under surge of new coronavirus cases

    Intensive care units in parts of Texas and Arizona are operating near full capacity

  • Tuesday, 30 June, 2020
    Coronavirus treatment
    The hedge fund manager behind a long-shot coronavirus pill

    Wayne Holman and his wife Wendy are betting they can change the course of the pandemic

  • Thursday, 25 June, 2020
    Coronavirus pandemic
    Texas puts reopening on hold in face of new outbreak

    State leads nation in new coronavirus cases as US tallies another one-day record increase

  • Tuesday, 23 June, 2020
    Coronavirus pandemic
    Fauci calls for more virus testing to counter ‘disturbing surge’

    US posts largest one-day increase in cases in almost two months, led by Texas and California

  • Tuesday, 23 June, 2020
    Coronavirus pandemic
    Kudlow dismisses ‘second wave’ fears as US cases jump

    White House economic official’s comments come as Texas governor notes ‘unacceptable rate’ virus is spreading

  • Monday, 22 June, 2020
    News in-depthCenters for Disease Control and Prevention
    US disease-fighting agency struggles as it seeks to avoid Trump’s ire

    ‘Tragic downgrading’ of storied CDC during coronavirus pandemic harms its reputation

  • Friday, 19 June, 2020
    Coronavirus treatment
    US biotech group to trial Covid-19 pill for use at home

    Ridgeback will test twice-daily tablet to treat mild cases as well as those seriously ill in hospital

  • Sunday, 14 June, 2020
    ExplainerDisease control and prevention
    Pop-up testing: how New Orleans bent the coronavirus curve 

    City had been on course for one of worst outbreaks in the US before focus on deprived communities

  • Tuesday, 9 June, 2020
    Coronavirus: free to read
    Why coronavirus has fuelled black America’s sense of injustice

    African-Americans have been especially vulnerable during the pandemic, laying bare disparities in health and employment

Previous You are on page 1 Next

Useful links

Support

View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

Legal & Privacy

Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

Services

FT LiveShare News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingContracts & Tenders
Executive Job SearchAdvertise with the FTFollow the FT on TwitterFT TransactSecondary Schools

Tools

PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School Rankings
Enterprise ToolsNews feedNewslettersCurrency Converter
More from the FT Group
Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2021. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
Financial Times

International Edition

  • Switch to UK Edition
  • Top sections
  • Home
  • World
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • Americas
    • Middle East and North Africa
  • US
    • US Economy
    • US Companies
    • US Politics & Policy
  • Companies
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
  • Tech
  • Markets
    • Alphaville
    • Markets Data
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
  • Climate
  • Opinion
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
  • Work & Careers
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
  • Life & Arts
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
  • Personal Finance
    • Property & Mortgages
    • Investments
    • Pensions
    • Tax
    • Banking & Savings
    • Advice & Comment
    • Next Act
  • How to Spend It
  • Special Reports
  • FT recommends
  • Graphics
  • Lex
  • Alphaville
  • Lunch with the FT
  • FT Globetrotter
  • #techAsia
  • Moral Money
  • FTfm
  • Newsletters
  • Video
  • Podcasts
  • News feed
  • myFT
  • Portfolio
  • Today's Newspaper (ePaper)
  • Crossword
  • Our Apps
  • Help Centre
  • Subscribe
  • Sign In